Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Creative Biostructure Provides Various Vaccine Development Services for Coronavirus

    Apr 5, 2021, 14:43 PM by
    Full story
  • CD BioSciences is Ready to Provide Clinical Data Management Service

    Apr 5, 2021, 14:43 PM by
    CD BioSciences, a US based supplier of one-stop clinical trial services, has announced to provide global scientists with clinical data management, analysis and reporting service.
    Full story
  • THREAD and Lokavant Partner to Provide Sponsors with First DCT Benchmarking Solution

    Apr 5, 2021, 14:43 PM by
    THREAD and Lokavant partner
    Full story
  • Alfa Chemistry Materials Releases Dye-Sensitized Solar Cell (DSSC) Materials

    Apr 5, 2021, 14:43 PM by
    Full story
  • Profacgen Provides Immunogenicity Testing Services to Help with Drug Discovery and Development

    Apr 5, 2021, 14:43 PM by
    Full story
  • DNAnexus Promotes Dr. Fan Fan to Chief Product Officer

    Apr 5, 2021, 14:43 PM by
    DNAnexus, Inc. today announced the promotion of Fan Fan, Ph.D., to Chief Product Officer. Dr. Fan will be responsible for driving the continued innovation and strategy for the company’s market-leading cloud platform for scientific analysis and collaboration.
    Full story
  • 2bPrecise Enhancements Deliver Deeper Oncology, Medication Safety Insights for Providers

    Apr 5, 2021, 14:43 PM by
    2bPrecise's winter 2021 release features advanced patient timeline to improve cancer care and analytics to identify patients at greatest risk for adverse drug reactions.
    Full story
  • Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site

    Apr 5, 2021, 14:43 PM by
    Panthera is enrolling Covid patients for AstraZeneca’s monoclonal antibody study to reduce disease severity.
    Full story
  • IntelyCare Honors Nursing Professionals and Facilities with Inaugural Healthcare Heroes Awards

    Apr 5, 2021, 14:43 PM by
    IntelyCare honors long-term care nursing professionals and facilities for their courageous work during the pandemic with its Healthcare Heroes Awards.
    Full story
  • Auxita and MyMeds&Me Announce Strategic Partnership to Deliver Integrated Digital Pharmacovigilance Capabilities

    Apr 5, 2021, 14:43 PM by
    This partnership integrates MyMeds&Me’s validated safety data capture solution into Auxita, enabling healthcare providers, patient support programs and pharmaceutical companies to capture and manage data more efficiently.
    Full story
  • Kyruus Completes Acquisition of HealthSparq, Paving Way for Seamless Cross-Channel Care Navigation

    Apr 5, 2021, 14:43 PM by
    Full story
  • EXTENSIVE OFFERING OF CLINICAL REFERENCE MATERIALS FOR BILIRUBIN TESTING NOW AVAILABLE FROM VERICHEM LABORATORIES

    Apr 5, 2021, 14:43 PM by
    VERICHEM LABORATORIES now offers medical laboratory professionals an extensive array of liquid stable, protein based, clinical reference material for CLIA compliance of Total and Direct Bilirubin assays.
    Full story
  • SYNCRONYS Leverages Orion Health to Launch Next-Generation Health Information Exchange in New Mexico

    Apr 5, 2021, 14:43 PM by
    State-of-the-Art HIE, Based on Orion Health’s Amadeus Platform and New Modules, Now Delivering Real-Time, Actionable Data for Providers, Payers, and other Stakeholders
    Full story
  • Follow the Money: Single-Cell Multiomics, Data Networks, Security

    Apr 1, 2021, 01:00 AM by User Not Found
    Bio-IT World | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.
    Full story
  • Viruses (And People) Play A ‘Signaling Game’ With Strangers And Dangers

    Mar 31, 2021, 01:00 AM by User Not Found
    Bio-IT World | Mathematically speaking, the cytokine storm seen with severe COVID-19 and the out-of-control behavior of QAnon conspiracy theorists are not really all that different, according to Bud Mishra, a professor at New York University's Courant Institute of Mathematical Sciences. Both invoke a stranger-danger “signaling game” that would also explain how messenger RNA (mRNA) and transfer RNA (tRNA) came to be cellular co-occupants some three and half billion years ago.
    Full story
  • Global Research Spanning 30+ Countries to Examine COVID’s Impact on the Brain

    Mar 30, 2021, 01:00 AM by User Not Found
    Bio-IT World | While it isn’t clear just yet how the coronavirus could impact cognition over the long haul, a global group of researchers is looking to learn more.
    Full story
  • 5 Important AI Discoveries Generated by COVID-19

    Mar 26, 2021, 01:00 AM by User Not Found
    Bio-IT World | Life sciences leaders are outlining the learnings from COVID-19 to move forward, hopefully stronger, wiser, and better than before.
    Full story
  • New Framework For Developing Polygenic Risk Scores

    Mar 25, 2021, 01:00 AM by User Not Found
    Bio-IT World | Last week a research team published a 22-item framework in Nature that identifies the minimal polygenic risk score-related information that scientists should include in their studies.
    Full story
  • Eric Dishman on Paul Allen, Andy Grove, and All of Us

    Mar 23, 2021, 01:00 AM by User Not Found
    Bio-IT World | TRENDS FROM THE TRENCHES—It’s been a little over a year since Eric Dishman stepped down as CEO of the National Institutes of Health’s All of Us program and took on the role of Chief Innovation Officer. Now he talks about his early training under Paul Allen of Microsoft and Andy Grove of Intel still plays into his decisions.
    Full story
  • eVideon Health Partners with Tampa General Hospital to Enhance Patients’ Experience

    Mar 19, 2021, 15:39 PM by
    Full story
  • «
  • 171
  • 172
  • 173
  • 174
  • 175 (current)
  • 176
  • 177
  • 178
  • 179
  • 180
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy